• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and China Biopharmaceutical Contract Manufacturing(BCMO) Market Size, Status and Forecast 2020-2026

report cover
  • 29 October 2020
  • Pharmaceuticals
  • 92 Pages
  • Report Code: 24LS-21668
  • Formate :   
Download FREE Report Sample Download PDF File

Biopharmaceutical Contract -MARKET ADVISORY SERVICES

Global Biopharmaceutical Contract Manufacturing(BCMO) Scope and Market Size
Biopharmaceutical Contract Manufacturing(BCMO) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical Contract Manufacturing(BCMO) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Mammalian Based Manufacturing
Microbial Based Manufacturing
Other

Market segment by Application, split into
Bio-Pharmaceutical Companies
Pharmaceutical Companies
Drug Discovery Companies
Other

Based on regional and country-level analysis, the Biopharmaceutical Contract Manufacturing(BCMO) market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Biopharmaceutical Contract Manufacturing(BCMO) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Lonza Group Ltd
Boehringher Ingelheim
Sandoz
Fujifilm Diosynth Biotechnology
Rentschler Biotechnologie
Celonic GmbH
BIOMEVA GmbH
ProBioGen AG
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Mammalian Based Manufacturing
1.2.3 Microbial Based Manufacturing
1.2.4 Other
1.3 Market by Application
1.3.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application: 2020 VS 2026
1.3.2 Bio-Pharmaceutical Companies
1.3.3 Pharmaceutical Companies
1.3.4 Drug Discovery Companies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Perspective (2015-2026)
2.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Growth Trends by Regions
2.2.1 Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biopharmaceutical Contract Manufacturing(BCMO) Historic Market Share by Regions (2015-2020)
2.2.3 Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Contract Manufacturing(BCMO) Players by Market Size
3.1.1 Global Top Biopharmaceutical Contract Manufacturing(BCMO) Players by Revenue (2015-2020)
3.1.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Players (2015-2020)
3.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing(BCMO) Revenue
3.4 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Concentration Ratio
3.4.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing(BCMO) Revenue in 2019
3.5 Key Players Biopharmaceutical Contract Manufacturing(BCMO) Area Served
3.6 Key Players Biopharmaceutical Contract Manufacturing(BCMO) Product Solution and Service
3.7 Date of Enter into Biopharmaceutical Contract Manufacturing(BCMO) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical Contract Manufacturing(BCMO) Breakdown Data by Type (2015-2026)
4.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Historic Market Size by Type (2015-2020)
4.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Type (2021-2026)

5 Biopharmaceutical Contract Manufacturing(BCMO) Breakdown Data by Application (2015-2026)
5.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Historic Market Size by Application (2015-2020)
5.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2015-2026)
6.2 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2015-2020)
6.3 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2015-2020)
6.4 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2015-2026)
7.2 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2015-2020)
7.3 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2015-2020)
7.4 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2015-2026)
8.2 China Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2015-2020)
8.3 China Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2015-2020)
8.4 China Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2015-2026)
9.2 Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2015-2020)
9.3 Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2015-2020)
9.4 Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2015-2026)
10.2 Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2015-2020)
10.3 Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2015-2020)
10.4 Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11 Key Players Profiles
11.1 Lonza Group Ltd
11.1.1 Lonza Group Ltd Company Details
11.1.2 Lonza Group Ltd Business Overview
11.1.3 Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Introduction
11.1.4 Lonza Group Ltd Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020))
11.1.5 Lonza Group Ltd Recent Development
11.2 Boehringher Ingelheim
11.2.1 Boehringher Ingelheim Company Details
11.2.2 Boehringher Ingelheim Business Overview
11.2.3 Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Introduction
11.2.4 Boehringher Ingelheim Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)
11.2.5 Boehringher Ingelheim Recent Development
11.3 Sandoz
11.3.1 Sandoz Company Details
11.3.2 Sandoz Business Overview
11.3.3 Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Introduction
11.3.4 Sandoz Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)
11.3.5 Sandoz Recent Development
11.4 Fujifilm Diosynth Biotechnology
11.4.1 Fujifilm Diosynth Biotechnology Company Details
11.4.2 Fujifilm Diosynth Biotechnology Business Overview
11.4.3 Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Introduction
11.4.4 Fujifilm Diosynth Biotechnology Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)
11.4.5 Fujifilm Diosynth Biotechnology Recent Development
11.5 Rentschler Biotechnologie
11.5.1 Rentschler Biotechnologie Company Details
11.5.2 Rentschler Biotechnologie Business Overview
11.5.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Introduction
11.5.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)
11.5.5 Rentschler Biotechnologie Recent Development
11.6 Celonic GmbH
11.6.1 Celonic GmbH Company Details
11.6.2 Celonic GmbH Business Overview
11.6.3 Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Introduction
11.6.4 Celonic GmbH Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)
11.6.5 Celonic GmbH Recent Development
11.7 BIOMEVA GmbH
11.7.1 BIOMEVA GmbH Company Details
11.7.2 BIOMEVA GmbH Business Overview
11.7.3 BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Introduction
11.7.4 BIOMEVA GmbH Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)
11.7.5 BIOMEVA GmbH Recent Development
11.8 ProBioGen AG
11.8.1 ProBioGen AG Company Details
11.8.2 ProBioGen AG Business Overview
11.8.3 ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Introduction
11.8.4 ProBioGen AG Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)
11.8.5 ProBioGen AG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables

Table 1. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 3. Key Players of Mammalian Based Manufacturing

Table 4. Key Players of Microbial Based Manufacturing

Table 5. Key Players of Other

Table 6. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 7. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Regions (US$ Million): 2020 VS 2026

Table 8. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Regions (2015-2020) (US$ Million)

Table 9. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Regions (2015-2020)

Table 10. Global Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 11. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Regions (2021-2026)

Table 12. Biopharmaceutical Contract Manufacturing(BCMO) Market Market Trends

Table 13. Biopharmaceutical Contract Manufacturing(BCMO) Market Drivers

Table 14. Biopharmaceutical Contract Manufacturing(BCMO) Market Challenges

Table 15. Biopharmaceutical Contract Manufacturing(BCMO) Market Restraints

Table 16. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Players (2015-2020) (US$ Million)

Table 17. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Players (2015-2020)

Table 18. Global Top Biopharmaceutical Contract Manufacturing(BCMO) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Contract Manufacturing(BCMO) as of 2019)

Table 19. Global Biopharmaceutical Contract Manufacturing(BCMO) by Players Market Concentration Ratio (CR5 and HHI)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Biopharmaceutical Contract Manufacturing(BCMO) Product Solution and Service

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2015-2020) (US$ Million)

Table 24. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Share by Type (2015-2020)

Table 25. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Type (2021-2026)

Table 26. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Share by Application (2015-2020)

Table 27. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2015-2020) (US$ Million)

Table 28. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Share by Application (2021-2026)

Table 29. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2015-2020) (US$ Million)

Table 30. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type (2015-2020)

Table 31. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2015-2020) (US$ Million)

Table 32. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application (2015-2020)

Table 33. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (US$ Million) (2015-2020)

Table 34. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Country (2015-2020)

Table 35. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2015-2020) (US$ Million)

Table 36. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type (2015-2020)

Table 37. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2015-2020) (US$ Million)

Table 38. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application (2015-2020)

Table 39. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (US$ Million) (2015-2020)

Table 40. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Country (2015-2020)

Table 41. China Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2015-2020) (US$ Million)

Table 42. China Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type (2015-2020)

Table 43. China Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2015-2020) (US$ Million)

Table 44. China Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application (2015-2020)

Table 45. China Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region (US$ Million) (2015-2020)

Table 46. China Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Region (2015-2020)

Table 47. Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2015-2020) (US$ Million)

Table 48. Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type (2015-2020)

Table 49. Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2015-2020) (US$ Million)

Table 50. Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application (2015-2020)

Table 51. Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (US$ Million) (2015-2020)

Table 52. Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Country (2015-2020)

Table 53. Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2015-2020) (US$ Million)

Table 54. Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type (2015-2020)

Table 55. Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2015-2020) (US$ Million)

Table 56. Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application (2015-2020)

Table 57. Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (US$ Million) (2015-2020)

Table 58. Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Country (2015-2020)

Table 59. Lonza Group Ltd Company Details

Table 60. Lonza Group Ltd Business Overview

Table 61. Lonza Group Ltd Product

Table 62. Lonza Group Ltd Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020) (US$ Million)

Table 63. Lonza Group Ltd Recent Development

Table 64. Boehringher Ingelheim Company Details

Table 65. Boehringher Ingelheim Business Overview

Table 66. Boehringher Ingelheim Product

Table 67. Boehringher Ingelheim Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020) (US$ Million)

Table 68. Boehringher Ingelheim Recent Development

Table 69. Sandoz Company Details

Table 70. Sandoz Business Overview

Table 71. Sandoz Product

Table 72. Sandoz Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020) (US$ Million)

Table 73. Sandoz Recent Development

Table 74. Fujifilm Diosynth Biotechnology Company Details

Table 75. Fujifilm Diosynth Biotechnology Business Overview

Table 76. Fujifilm Diosynth Biotechnology Product

Table 77. Fujifilm Diosynth Biotechnology Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020) (US$ Million)

Table 78. Fujifilm Diosynth Biotechnology Recent Development

Table 79. Rentschler Biotechnologie Company Details

Table 80. Rentschler Biotechnologie Business Overview

Table 81. Rentschler Biotechnologie Product

Table 82. Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020) (US$ Million)

Table 83. Rentschler Biotechnologie Recent Development

Table 84. Celonic GmbH Company Details

Table 85. Celonic GmbH Business Overview

Table 86. Celonic GmbH Product

Table 87. Celonic GmbH Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020) (US$ Million)

Table 88. Celonic GmbH Recent Development

Table 89. BIOMEVA GmbH Company Details

Table 90. BIOMEVA GmbH Business Overview

Table 91. BIOMEVA GmbH Product

Table 92. BIOMEVA GmbH Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020) (US$ Million)

Table 93. BIOMEVA GmbH Recent Development

Table 94. ProBioGen AG Business Overview

Table 95. ProBioGen AG Product

Table 96. ProBioGen AG Company Details

Table 97. ProBioGen AG Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020) (US$ Million)

Table 98. ProBioGen AG Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type: 2020 VS 2026

Figure 2. Mammalian Based Manufacturing Features

Figure 3. Microbial Based Manufacturing Features

Figure 4. Other Features

Figure 5. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application: 2020 VS 2026

Figure 6. Bio-Pharmaceutical Companies Case Studies

Figure 7. Pharmaceutical Companies Case Studies

Figure 8. Drug Discovery Companies Case Studies

Figure 9. Other Case Studies

Figure 10. Biopharmaceutical Contract Manufacturing(BCMO) Report Years Considered

Figure 11. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size (US$ Million), YoY Growth 2015-2026

Figure 12. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Regions: 2020 VS 2026

Figure 13. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Regions (2021-2026)

Figure 14. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Players in 2019

Figure 15. Global Top Biopharmaceutical Contract Manufacturing(BCMO) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Contract Manufacturing(BCMO) as of 2019

Figure 16. The Top 10 and 5 Players Market Share by Biopharmaceutical Contract Manufacturing(BCMO) Revenue in 2019

Figure 17. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 18. United States Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 19. Canada Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 20. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 21. Germany Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 22. France Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 23. U.K. Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 24. Italy Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 25. Russia Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 26. Nordic Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 27. Rest of Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 28. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 29. China Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 30. Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 31. South Korea Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 32. Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 33. India Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 34. Australia Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 35. Rest of Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 36. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 37. Mexico Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 38. Brazil Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 39. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 40. Turkey Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 41. Saudi Arabia Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 42. UAE Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 43. Rest of Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 44. Lonza Group Ltd Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)

Figure 45. Boehringher Ingelheim Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)

Figure 46. Sandoz Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)

Figure 47. Fujifilm Diosynth Biotechnology Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)

Figure 48. Rentschler Biotechnologie Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)

Figure 49. Celonic GmbH Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)

Figure 50. BIOMEVA GmbH Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)

Figure 51. ProBioGen AG Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2015-2020)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

Lonza Group Ltd

Boehringher Ingelheim

Sandoz

Fujifilm Diosynth Biotechnology

Rentschler Biotechnologie

Celonic GmbH

BIOMEVA GmbH

ProBioGen AG

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3315

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase